| Date Filed | Type | Description |
| 07/06/2023 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 12,946 shares
@ $3.08, valued at
$39.9k
|
|
| 07/06/2023 |
4
| Requadt Scott (Former Chief Executive Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 11,786 shares
@ $3.08, valued at
$36.3k
|
|
| 06/09/2023 |
4
| Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Sold 75,001 shares
@ $2.3879, valued at
$179.1k
Sold 40,642 shares
@ $2.4795, valued at
$100.8k
Sold 25,419 shares
@ $2.4642, valued at
$62.6k
|
|
| 06/07/2023 |
4
| Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Sold 7,841 shares
@ $2.5194, valued at
$19.8k
Sold 25,549 shares
@ $2.5283, valued at
$64.6k
|
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2023 |
4
| Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Sold 29 shares
@ $2.05, valued at
$59.5 |
|
| 02/23/2023 |
4
| Ildstad Suzanne (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $2.0529, valued at
$7.2k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| Zdanowski Michael (Chief Technology Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 120,000 shares
@ $0 |
|
| 09/13/2022 |
4
| Krieger Nancy (Chief Medical Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 09/13/2022 |
4
| Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 09/13/2022 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 09/13/2022 |
4/A
| Nader Francois (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $3.52, valued at
$176k
Bought 52,000 shares
@ $3.62, valued at
$188.2k
Disposed of 248,432 shares
@ $0
Acquired 248,432 shares
@ $0
Bought 36,500 shares
@ $3.72, valued at
$135.8k
Disposed of 138,500 shares
@ $0
Acquired 138,500 shares
@ $0 |
|
| 08/23/2022 |
4
| Ildstad Suzanne (Chief Scientific Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Sold 525,000 shares
@ $2.8, valued at
$1.5M
|
|
| 08/02/2022 |
4
| Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Bought 39,382 shares
@ $4.25, valued at
$167.4k
|
|
| 07/28/2022 |
4
| Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Bought 5,528 shares
@ $4.24, valued at
$23.4k
Bought 3,090 shares
@ $4.25, valued at
$13.1k
|
|
| 07/26/2022 |
4
| Requadt Scott (CEO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Bought 9,444 shares
@ $3.7497, valued at
$35.4k
|
|
| 07/25/2022 |
4
| Nader Francois (Director) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $3.52, valued at
$176k
Bought 52,000 shares
@ $3.62, valued at
$188.2k
Disposed of 248,432 shares
@ $0
Acquired 248,432 shares
@ $0
Bought 36,500 shares
@ $3.72, valued at
$135.8k
Disposed of 138,500 shares
@ $0
Acquired 138,500 shares
@ $0 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Agarwala Sandip (10% Owner) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 14,501 options to buy
@ $8.45, valued at
$122.5k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2022 |
4
| Ildstad Suzanne (Chief Scientific Officer) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Gifted 1,200,000 shares
@ $0
Gifted 1,200,000 shares
@ $0
Granted 150,000 options to buy
@ $9.1, valued at
$1.4M
|
|
|